LALILAB
- Company typePrivate
- Founded-
- HeadquartersDurham, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
LALILAB firmographics
Firmographics- Name
- LALILAB
- Legal name
- Lalilab, Inc.
- Website
- https://lalilab.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
LALILAB industry classification
Industry- Product category
- Specialty Ingredient Distribution
- NAICS
- Medicinal and Botanical Manufacturing (325411), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Wholesale-Chemicals & Allied Products (5160)
- akta.pro primary industry
- Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO)
Keywords
Where LALILAB is headquartered
LocationHeadquarters
- HQ city
- Durham
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
LALILAB business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D
Revenue model
- Ingredient Distribution: LALILAB generates revenue through the sourcing and distribution of high-quality raw materials including fine chemicals, botanical extracts, and pharmaceutical APIs to pharmaceutical, nutraceutical, and food industries
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | B2B ingredient sourcing - pricing available upon inquiry |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
LALILAB product offering
Product offeringCore offering
LALILAB is a specialty ingredient sourcing and distribution company that supplies high-quality raw materials to the pharmaceutical, nutraceutical, and food industries. The company distributes three core product categories—Fine Chemicals (amino acids, nucleotides, vitamins, coenzymes, specialty biochemicals), Botanicals (plant extracts and herbal ingredients), and Pharmaceutical APIs (antibiotics, corticosteroids, steroid hormones, nucleic acid derivatives)—sourced from a global network of more than 50 manufacturers across 15 countries operating under non-disclosure and exclusive agreements, with on-site quality control and climate-controlled warehousing at its Durham, NC facility.
Product overview
LALILAB is a family-owned ingredient sourcing company specializing in high quality raw materials for pharmaceutical, nutraceutical, and food industries. The company operates three core product divisions: Fine Chemicals (amino acids, nucleotides, vitamins, coenzymes, and specialty biochemicals), Botanicals (plant extracts and herbal ingredients), and Pharmaceutical APIs (antibiotics, corticosteroids, steroid hormones, and other active ingredients). Under non-disclosure and exclusive agreements, LALILAB maintains a unique global network of ingredient manufacturers across more than 50 manufacturers in 15 countries, enabling them to source specialized compounds and innovative new ingredients for their customers.
Differentiator
Problem solved
Functional benefit
Products and services
- Fine Chemicals
- Botanicals
- Pharmaceutical APIs
Quantifiable outcome
- Same-day order processing and shipping for urgent orders
- +1 more outcomes
Companies that use LALILAB
Customer profileSegments3 records
Ideal customer profiles3 records
LALILAB technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
LALILAB partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Chr. Olesen GroupmajorChr. Olesen Group, a fifth-generation Danish family-owned ingredients distributor, completed a merger of its US subsidiary with Lalilab. This strategic combination merges two family-owned businesses with strong histories in ingredients distribution, expanding Chr. Olesen's US footprint while giving Lalilab access to a broader range of food and pharma-related products. The deal was arranged by M&A advisor ThinkingLinking and reflects broader trends toward global consolidation in the natural ingredients sector.
Scale indicators3 records
Recent moves5 records
Expansion highlights5 records
LALILAB competitors and assessment
Company assessmentDirect peers
- Indena SpA: Italian manufacturer and supplier of standardized botanical extracts and APIs for the pharmaceutical and nutraceutical industries. Most direct competitor to Lalilab's botanical-extracts business with similar botanical sourcing expertise.
- Chr. Olesen Group: Fifth-generation Danish ingredients distributor serving pharmaceutical, nutraceutical, and food customers. Now the parent/merged entity of LALILAB, it is the most directly comparable peer given overlapping product categories and end-markets.
- Parchem - Fine & Specialty Chemicals: Specialty and fine chemical distributor serving pharmaceutical, nutraceutical, and personal care manufacturers with a similar sourcing-and-distribution model and quote-based pricing.
- Cayman Chemical: Supplier of fine chemicals, biochemicals, APIs, and research reagents to pharma and life-science customers. Comparable to Lalilab's fine-chemicals and APIs offerings with overlapping CAS-driven catalog.
- Spectrum Chemical Manufacturing Corporation: US-based distributor of fine chemicals, APIs, excipients, and laboratory reagents to pharmaceutical, nutraceutical, and food manufacturers. Direct competitor on the ingredient distribution side of Lalilab's catalog.
- TCI Chemicals (Tokyo Chemical Industry): Global distributor of fine chemicals, organic intermediates, and specialty reagents for pharmaceutical and research end-users. Overlaps with Lalilab's fine-chemicals focus and similar international sourcing footprint.
Broad incumbents
- Alfa Aesar (Thermo Fisher Scientific): Catalog distributor of fine chemicals, reagents, and metals serving pharma, academic, and industrial labs as part of Thermo Fisher. Wider catalog and global scale than Lalilab, but competes in the same fine-chemicals segment.
- Sigma-Aldrich (Merck KGaA, Life Science): Largest global supplier of specialty chemicals, reagents, and APIs serving pharmaceutical and life-science customers. Establishes the upper-bound competitive baseline that Lalilab competes against in fine chemicals and APIs.
- Bio-Techne Corporation: Supplier of high-purity proteins, reagents, and biochemicals to pharma and research customers. Broader reagents portfolio but overlaps with Lalilab's biochemicals/nucleic-acid-derivative offering.
Emerging players
- Santa Cruz Biotechnology: Supplier of antibodies, biochemicals, and fine chemicals for research and pharma. Comparable to Lalilab in the fine-chemicals/biochemicals category, focused on research and small-volume specialty orders.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
LALILAB social profiles
Digital presenceLALILAB compliance and trust
Trust signalCompliance1 record
LALILAB financial estimates
Financial estimateRevenue estimate
Valuation estimate
LALILAB leadership team
Management profileNumber of profiles
Profiles1 record
LALILAB funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
LALILAB M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about LALILAB
What does LALILAB do?
LALILAB is a specialty ingredient sourcing and distribution company that supplies high-quality raw materials to the pharmaceutical, nutraceutical, and food industries. The company distributes three core product categories—Fine Chemicals (amino acids, nucleotides, vitamins, coenzymes, specialty biochemicals), Botanicals (plant extracts and herbal ingredients), and Pharmaceutical APIs (antibiotics, corticosteroids, steroid hormones, nucleic acid derivatives)—sourced from a global network of more than 50 manufacturers across 15 countries operating under non-disclosure and exclusive agreements, with on-site quality control and climate-controlled warehousing at its Durham, NC facility.
Is LALILAB a public or private company?
LALILAB is a private company. It is classified as corporate owned and is currently operating.
When was LALILAB founded?
LALILAB was founded in -1. It employs 11 to 50 people.
Where is LALILAB based?
LALILAB is headquartered in Durham, United States, in the North America region.
How does LALILAB make money?
One revenue line is on record: ingredient Distribution.
Who are LALILAB's main competitors?
Direct peers on record are Indena SpA, Chr. Olesen Group, Parchem - Fine & Specialty Chemicals, Cayman Chemical, Spectrum Chemical Manufacturing Corporation and TCI Chemicals (Tokyo Chemical Industry). Broad incumbents are Alfa Aesar (Thermo Fisher Scientific), Sigma-Aldrich (Merck KGaA, Life Science) and Bio-Techne Corporation. Santa Cruz Biotechnology is listed as an emerging player.
Does LALILAB have an API?
No public API is recorded for LALILAB.
What industry is LALILAB in?
LALILAB's product category is Specialty Ingredient Distribution. Its primary akta.pro industry code is HLAIAJAO, Compounding Ingredient & API Distributors (Pharma Supply). Its NAICS code is 325411 and its SIC code is 2833.